Julia Boorstin reports the latest on Disney’s amended offer for Fox assets in the bidding war against Comcast.

Comcast announced a $65 billion bid for Twenty-First Century Foxunits that are currently in an agreement to be acquired by Disney. The bid, announced Wednesday, represents a 19 percent premium to Disney’s offer. Comcast, the parent of CNBC, offered $35 a share in cash. Disney agreed in December to buy the majority of Fox for $52.4 billion in …

Walt Disney Co. and 21st Century Fox are closing in on a deal, according to sources familiar with the matter.

Starwood Hotels & Resorts has received a rival takeover bid worth about $14 billion from a group of investors led by a Chinese firm that’s been quite active in buying up U.S. hotel properties, including the Waldorf-Astoria.

Newell Rubbermaid announced plans to acquire Jarden Brands for $16 billion.

DuPont and Dow Chemical, two of America’s oldest companies, are reportedly in advanced stage merger talks that would create a chemical powerhouse.

Congress is taking a closer look at the proposed merger that would create the world’s largest beer company.

Does the $14 billion buyout of Keurig Green Mountain make sense?

Personal beverage system company Keurig Green Mountain has agreed to be taken private by an investor group led by JAB Holding for $92 a share in cash. The companies value the total equity of the deal at about $13.9 billion, and represents a premium of approximately 77.9 percent over Keurig’s closing stock price on December …

Pfizer and Allergan are combining in a $160 billion deal, handing Pfizer a new address and creating a lot of controversy.

Marriott wants to buy Starwood Hotels to create the world’s largest hotel company.

Falling commodity prices are hurting the railroads and that’s one reason why there could be more consolidation in the industry.

Visa is aggressively expanding its global footprint with its biggest acquisition ever.

Pfizer and Allergan are in merger talks that could create the world’s largest pharmaceutical company.

Ireland-based Allergan on Thursday confirmed that it has been approached by Pfizer and is in talks regarding a potential deal with the U.S. drug company, raising questions about another pharmaceutical tax inversion. Allergan said no agreement had been reached, describing the talks as “preliminary and friendly.” Shares of Allergan popped about 9 percent in early …